FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Park Avenue Compounding Phenylephrine HCI Recall

Phenylephrine HCI, 1000 mcg / 10 mL, 10 mL Total Volume, Rx Only, Park Avenue Compoundi…

Park Avenue Compounding · Saint Louis, MO

Risk level
Class II
Reported by FDA
Dec 10, 2025
Recall ID
D-0200-2026
Check your lot numberHow we source this data

Summary

Park Avenue Compounding recalled Phenylephrine HCI starting Sep 17, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0200-2026 on Dec 10, 2025. Reason: CGMP Deviations. Status: Ongoing.

Why it was recalled

CGMP Deviations

Product description

Phenylephrine HCI, 1000 mcg / 10 mL, 10 mL Total Volume, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110-2512, NDC 83863-0104-1.

Lot numbers, UPCs & expiration codes

Lot # 20250813-13D65E, Exp Date: FEB-09-2026.

Where it was sold

MO

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0200-2026
Classification
Class II
Status
Ongoing
Recall initiated
Sep 17, 2025
FDA report date
Dec 10, 2025
Quantity
858 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
Park Avenue Compounding

Original FDA data

Every field from FDA enforcement report D-0200-2026, exactly as published.

Show all FDA fields
City
Saint Louis
State
MO
Status
Ongoing
Country
United States
Event ID
97960
Address
3662 Park Ave Ste 140
Code information
Lot # 20250813-13D65E, Exp Date: FEB-09-2026.
Postal code
63110-2512
Report date
Dec 10, 2025
Product type
Drugs
Recall number
D-0200-2026
Classification
Class II
Recalling firm
Park Avenue Compounding
Product quantity
858 syringes
Reason for recall
CGMP Deviations
Voluntary / mandated
Voluntary: Firm initiated
Product description
Phenylephrine HCI, 1000 mcg / 10 mL, 10 mL Total Volume, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110-2512, NDC 83863-0104-1.
Distribution pattern
MO
Recall initiation date
Sep 17, 2025
Initial firm notification
Letter
Center classification date
Dec 2, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0200-2026, published Dec 10, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls